MyFinsight
Home
Blog
About
Contact
Download
Download image
Non-cash impairment
charges
$511,365K
Proceeds from borrowings
of long-term...
$720,700K
Depreciation and
amortization
$151,832K
Accounts payable,
accrued expenses and...
$26,724K
Share-based compensation
$18,583K
Amortization of debt issuance
costs and expenses...
$5,605K
Contract liabilities
$3,400K
Other non-current
assets
-$3,343K
Lease incentive
$1,299K
Loss on disposal of
property and equipment...
-$490K
Proceeds from exercise of
stock options and...
$957K
Net cash provided by
operating activities
$50,384K
Net cash provided by
(used in) financing...
$28,335K
Effect of exchange rate
changes on cash and cash...
$18,017K
Canceled cashflow
$672,257K
Canceled cashflow
$693,322K
Net decrease in cash
and cash...
-$11,327K
Canceled cashflow
$96,736K
Proceeds from maturities
of short-term...
$7,000K
Net (loss) income
-$516,474K
Deferred income tax
benefit
-$66,264K
Inventories
$46,760K
Change in fair value of
contingent consideration...
-$21,329K
Other non-current
liabilities
-$17,156K
Prepaid expenses and
other current assets
$2,802K
Non-cash lease expense
-$987K
Accounts receivable
$485K
Repayments of convertible
debt
$574,983K
Payments on debt
$94,906K
Payments for contingent
considerations
$16,451K
Payment of debt issuance
costs
$4,064K
Cash taxes paid in net
equity settlement
$2,697K
Purchase of treasury
stock
$221K
Net cash used in
investing activities
-$108,063K
Canceled cashflow
$7,000K
Purchases of property and
equipment
$81,436K
Purchases of intangible
assets
$14,202K
Net (payment)
proceeds on swaps...
$10,923K
Purchases of short-term
investments
$8,502K
Back
Back
Cash Flow
source: myfinsight.com
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)